Clinical Trial Update: Effect of Sulodexide in Overt Diabetic Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 trial update for sulodexide in overt diabetic nephropathy; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Sulodexide (sulodexide)

Snippet

Sponsor: Keryx Biopharmaceuticals | Conditions: Diabetic Nephropathy | Phase 4 | Status: TERMINATED